Literature DB >> 25572989

Evolution of evidence-based medicine to detect evidence mutations.

Brian S Alper1, Zbys Fedorowicz2, Sheri A Strite3, Michael E Stuart4, Allen F Shaughnessy5.   

Abstract

Mesh：

Year:  2015        PMID： 25572989      PMCID： PMC4291324          DOI： 10.1177/0141076814555936

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  17 in total

1.  Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

Authors:  Benjamin M Scirica; Deepak L Bhatt; Eugene Braunwald; P Gabriel Steg; Jaime Davidson; Boaz Hirshberg; Peter Ohman; Robert Frederich; Stephen D Wiviott; Elaine B Hoffman; Matthew A Cavender; Jacob A Udell; Nihar R Desai; Ofri Mosenzon; Darren K McGuire; Kausik K Ray; Lawrence A Leiter; Itamar Raz
Journal:  N Engl J Med       Date:  2013-09-02       Impact factor: 91.245

2.  Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

Authors:  William B White; Christopher P Cannon; Simon R Heller; Steven E Nissen; Richard M Bergenstal; George L Bakris; Alfonso T Perez; Penny R Fleck; Cyrus R Mehta; Stuart Kupfer; Craig Wilson; William C Cushman; Faiez Zannad
Journal:  N Engl J Med       Date:  2013-09-02       Impact factor: 91.245

3.  Retraction. Low sodium versus normal sodium diets in systolic heart failure: systematic review and meta-analysis. Heart. Published Online First: 21 August 2012 doi:10.1136/heartjnl-2012-302337.

Authors: 
Journal:  Heart       Date:  2013-06       Impact factor: 5.994

4.  Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus.

Authors:  Harshal R Patil; Firas J Al Badarin; Hamza A Al Shami; Salman K Bhatti; Carl J Lavie; David S H Bell; James H O'Keefe
Journal:  Am J Cardiol       Date:  2012-06-15       Impact factor: 2.778

5.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

6.  Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial.

Authors:  Amy U Theos; Rebecca Cummins; Nanette B Silverberg; Amy S Paller
Journal:  Cutis       Date:  2004-08

7.  Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials.

Authors:  M Monami; B Ahrén; I Dicembrini; E Mannucci
Journal:  Diabetes Obes Metab       Date:  2012-09-20       Impact factor: 6.577

8.  Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency.

Authors:  J C N Chan; R Scott; J C Arjona Ferreira; D Sheng; E Gonzalez; M J Davies; P P Stein; K D Kaufman; J M Amatruda; D Williams-Herman
Journal:  Diabetes Obes Metab       Date:  2008-06-01       Impact factor: 6.577

Review 9.  Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery.

Authors:  Sonia Bouri; Matthew James Shun-Shin; Graham D Cole; Jamil Mayet; Darrel P Francis
Journal:  Heart       Date:  2013-07-31       Impact factor: 5.994

10.  Evidence based medicine: a movement in crisis?

Authors:  Trisha Greenhalgh; Jeremy Howick; Neal Maskrey
Journal:  BMJ       Date:  2014-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.